Auteurs

David Mulder

Counsel

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More
Auteurs

David Mulder

Counsel

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More

9 novembre 2020

Pharmaceutical patent law – 1 de 2 Publications

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

Dans cette série

Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9 November 2020

par plusieurs auteurs

Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23 November 2020

par plusieurs auteurs

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22 mars 2024
Briefing

par Dr. Anja Lunze, LL.M. et Tobias Baus, LL.M., Dipl.-Ing.

Cliquer ici pour en savoir plus
UPC

The first 100 days of the UPC from a life sciences perspective – a very good message

20 septembre 2023
Quick read

par Dr. Anja Lunze, LL.M. et Dr. Nora E. Wessendorf, LL.M. (Washington)

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Personalised medicines and exclusive protection

19 juillet 2023

par Dr Paul England

Cliquer ici pour en savoir plus